973 studies found for:    "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Completed A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
22 Recruiting c-Met Second-Line Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: MSC2156119J
23 Completed Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
24 Completed
Has Results
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin;   Drug: Doxorubicin/Placebo
25 Not yet recruiting TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Carcinoma, Hepatocellular
Interventions: Procedure: TACE;   Drug: sorafenib combined with TACE
26 Completed Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Refametinib (BAY86-9766)
27 Completed Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
28 Terminated Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Thalidomide(Thado)
29 Completed Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Capecitabine in HCC
30 Active, not recruiting Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Hepatoma
Interventions: Device: Bead Block microspheres;   Other: Bead + Dox Arm
31 Completed
Has Results
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
32 Unknown  Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
33 Completed
Has Results
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Placebo
34 Unknown  Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Conditions: Carcinoma, Hepatocellular;   Cirrhosis
Intervention: Procedure: Liver transplantation
35 Recruiting Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Refametinib (BAY86-9766);   Drug: Sorafenib (BAY43-9006)
36 Withdrawn Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
Conditions: Liver Cirrhosis;   Carcinoma, Hepatocellular
Intervention:
37 Not yet recruiting Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction];   Liver Neoplasms;   Carcinoma, Hepatocellular;   Digestive System Neoplasms;   Neoplasms by Site;   Liver Diseases;   Adenocarcinoma;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction];   HBV
Interventions: Procedure: Transarterial Chemoembolization (TACE);   Other: Sorafenib in combination with TACE
38 Completed TK-based Suicide Gene Therapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: TK99UN
39 Recruiting Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
40 Active, not recruiting Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Liver Dysfunction
Interventions: Drug: Gd-EOB-DTPA;   Procedure: MRI

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years